Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.


TSXV:RX - Post by User

Bullboard Posts
Comment by kingposton Sep 08, 2014 6:59pm
204 Views
Post# 22917423

RE:RE:Paladin 2.0 Fastforward.....

RE:RE:Paladin 2.0 Fastforward.....funny that Eugene Melinyk is po pooing tax inversions knowing that it was he who set up Biovail that way ..way back....anyway, yes RX has a simple Canadian struture , and I consider this a positive ...I could see a mini market crash of the tax inversions if the US does come down on them,,But imo I would much rather the business stand on its own two feet, instead relying on its business strategy... There are other less obvious problems with tax inversions also, for example, if you were the FDA reviewing a NDA, or clinical trial,  from a company who just did a tax inversion, knowing also that business market share will go to the inverted co from other non inverted cos,  whould this shade your judgement... On the same tact, RX workes with govt's on getting approvals--- you see what I am thinking... 
All that said, rx still could benefit from tax differences simply because canadian corporate taxes are less than US ... and if a us co wanted to lower its taxes to canadian levels they could buy out rx... but that is not something  we have to focus on because rx will continue to benefit canadians with mediical products  and also support the Canadian tax structurewith its simple and honest structure.
Bullboard Posts